Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2015/AstraZeneca-and-Ironwood-Report-Positive-Top-Line-Data-from-Phase-III-IBS-C-Trial-Designed-to-Support-Linaclotide-Approval-in-China/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here